343 ETH (Benazepril 20 mg)
Pill imprint 343 ETH has been identified as Benazepril hydrochloride 20 mg.
Benazepril is used in the treatment of high blood pressure; diabetic kidney disease; left ventricular dysfunction; heart failure and belongs to the drug class angiotensin converting enzyme inhibitors. There is positive evidence of human fetal risk during pregnancy. Benazepril 20 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for 343 ETH (Benazepril 20 mg)
- 20 mg
- 8.00 mm
- Prescription only
- Drug Class:
- Angiotensin converting enzyme inhibitors
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- N - Not a controlled drug
- Ethex Corporation
- National Drug Code (NDC):
- Inactive Ingredients:
- carnauba wax
silicon dioxide colloidal
ferric oxide black
yellow iron oxide
|NDC Code||Manufacturer / Repackager|
|54569-5669||A S Medication Solutions LLC (repackager)|
|66336-0691||Dispensing Solutions Inc. (repackager)|
|68071-0146||Nucare Pharmaceuticals Inc (repackager)|
Note: Inactive ingredients may vary.
More about benazepril
- Other brands: Lotensin